237 related articles for article (PubMed ID: 7711142)
1. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.
Zitvogel L; Tahara H; Cai Q; Storkus WJ; Muller G; Wolf SF; Gately M; Robbins PD; Lotze MT
Hum Gene Ther; 1994 Dec; 5(12):1493-506. PubMed ID: 7711142
[TBL] [Abstract][Full Text] [Related]
2. Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
Okada H; Attanucci J; Tahara H; Pollack IF; Bozik ME; Chambers WH; Lotze MT
Cancer Gene Ther; 2000 Mar; 7(3):486-94. PubMed ID: 10766355
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
Harries M; Phillipps N; Anderson R; Prentice G; Collins M
J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
[TBL] [Abstract][Full Text] [Related]
4. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
[TBL] [Abstract][Full Text] [Related]
5. Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12).
Paul D; Qazilbash MH; Song K; Xu H; Sinha BK; Liu J; Cowan KH
Cancer Gene Ther; 2000 Feb; 7(2):308-15. PubMed ID: 10770641
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
[TBL] [Abstract][Full Text] [Related]
7. [The construction and application of adenovirus vector coexpressing the heterodimer of human IL-12].
Zhang W; Cao X
Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):33-6. PubMed ID: 10923401
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of a recombinant adenoviral vector expressing human interleukin-12.
Qiao J; Chen SH; Pham-Nguyen KB; Mandeli J; Woo SL
Cancer Gene Ther; 1999; 6(4):373-9. PubMed ID: 10419056
[TBL] [Abstract][Full Text] [Related]
9. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
Tahara H; Zitvogel L; Storkus WJ; Zeh HJ; McKinney TG; Schreiber RD; Gubler U; Robbins PD; Lotze MT
J Immunol; 1995 Jun; 154(12):6466-74. PubMed ID: 7759882
[TBL] [Abstract][Full Text] [Related]
10. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.
Bramson J; Hitt M; Gallichan WS; Rosenthal KL; Gauldie J; Graham FL
Hum Gene Ther; 1996 Feb; 7(3):333-42. PubMed ID: 8835220
[TBL] [Abstract][Full Text] [Related]
11. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
[TBL] [Abstract][Full Text] [Related]
12. Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA.
Boggs SS; Patrene KD; Mueller GM; Evans CH; Doughty LA; Robbins PD
Gene Ther; 1995 Nov; 2(9):632-8. PubMed ID: 8548552
[TBL] [Abstract][Full Text] [Related]
13. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
Gastl G; Finstad CL; Guarini A; Bosl G; Gilboa E; Bander NH; Gansbacher B
Cancer Res; 1992 Nov; 52(22):6229-36. PubMed ID: 1423266
[TBL] [Abstract][Full Text] [Related]
14. A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotype.
Melani C; Sulé-Suso J; Arienti F; MacCalli C; Passerini F; Colombo MP; Parmiani G
Hum Gene Ther; 1995 Nov; 6(11):1427-36. PubMed ID: 8573615
[TBL] [Abstract][Full Text] [Related]
15. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
16. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
Nagashima S; Mailliard R; Kashii Y; Reichert TE; Herberman RB; Robbins P; Whiteside TL
Blood; 1998 May; 91(10):3850-61. PubMed ID: 9573023
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
18. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site].
Fu J; Chen Z; Wang W
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):619-22. PubMed ID: 11263327
[TBL] [Abstract][Full Text] [Related]
19. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
20. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
Byun J; Kim JM; Robbins PD; Kim S
Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
